Retatrutide 10mg

Retatrutide is a 39-amino-acid synthetic peptide that functions as a triple agonist at the GLP-1, GIP and glucagon receptors. By engaging all three incretin and glucagon pathways at once, it has been investigated for its combined effects on insulin secretion, energy expenditure, lipolysis and hepatic glucose output, and is one of the most-studied triple agonists in modern metabolic research.

This 10mg lyophilised peptide vial is supplied for reconstitution with bacteriostatic water and is well suited to pilot studies, early dose-finding work and short receptor-binding assays where a smaller quantity of high-purity material is preferred over a bulk research format.

Research Applications • Investigation of simultaneous GLP-1, GIP and glucagon receptor activation • Studies on energy expenditure, thermogenesis and lipid oxidation pathways • Characterisation of hepatic glucose production and glycaemic dynamics • Comparative pharmacology against single and dual incretin reference peptides

Specification • Identity: Retatrutide (CAS 2381089-83-2) • Molecular weight: 4875.42 g/mol • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised peptide vial — reconstitute with bacteriostatic water before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.